SYNOPSIS Liver cell dysplasia is defined as cellular enlargement, nuclear pleomorphism, and multinucleation of liver cells occurring in groups or occupying whole cirrhotic nodules. The prevalence, natural history, and relationship to the Australia or hepatitis-associated antigen (HAA) have been studied in 552 Ugandan African patients with normal, cirrhotic, and cancerous livers. Liver cell dysplasia was found in only two of 200 (1 %) patients with normal livers, in three of 43 (6-9 %) of patients with normal livers bearing primary liver cell carcinoma, 35 of 175 (203 %) patients with cirrhosis, and 80 of 124 (64 5 %) of patients with cirrhosis and primary liver cell carcinoma. Cirrhotic patients without dysplasia were, on average, ten years younger than those with dysplasia and the latter were on average six years younger than those with cirrhosis and carcinoma. Liver cell dysplasia occurred more frequently in males than in females. It was found in all but one instance in macronodular or mixed forms of cirrhosis only. There was a strong relationship between dysplasia and the presence of HAA in 104 patients that suggests a possible carcinogenic mechanism for the longincubation (serum or B) hepatitis virus in liver cell carcinoma. It is concluded that the presence of liver cell dysplasia identifies a group of patients with a high risk of liver cell carcinoma and that they should be followed up by serial alpha-fetoprotein estimations.
Gross morphological abnormality of liver cells in cirrhosis has been noted from time to time (Edmondson and Steiner, 1954; Steiner and Davies, 1957; Higginson and Steiner, 1961) , particularly in the macronodular (posthepatitic or postnecrotic) types (Scheuer, 1968) . The terms 'liver cell atypia', 'hyperplastic nodule', and 'regeneration' have been applied to this change. Steiner and Davies (1957) commented on its relative frequency in African, as compared with American cirrhotic livers. The distinction between an atypical nodule and well differentiated liver cell carcinoma may be difficult (Higginson and Steiner, 1961) . However, these foci of cellular atypia have not been thought to represent a premalignant or malignant change, the arguments against this being that the histopathological features were different from carcinomas arising in the same livers (Steiner and Davies, 1957) or that such foci could persist in cirrhotic livers for years without carcinoma supervening (Scheuer, 1968) . In experimental pathology similar changes may be produced by a variety of means and their interpretation remains uncertain (Butler, 1971) .
Received for publication 23 January 1973. The considerable disagreement about the true nature of this phenomenon is reflected in the variety of names applied to it. We have chosen 'liver cell dysplasia' as the most appropriate term to describe the histological appearances and the least presumptive as to their nature.
In the course of our continuing studies of primary liver cancer in Uganda we have noted an association of liver cell dysplasia with macronodular types of cirrhosis and carcinoma of liver cell, but not of bile duct, origin (Anthony, 1972) , and we have also found a highly significant association with the presence of the Australia or hepatitis-associated antigen (HAA) (Anthony, Vogel, Sadikali, Barker, and Peterson, 1972 (Hutt, 1971 The presence of HAA was tested for in 125 cases by complement fixation (Shulman and Barker, 1969) and counterelectrophoresis (Gocke and Howe, 1970) . Alpha-fetoprotein (AFP) was assayed in 134 cases by immunodiffusion (Abelev, 1968) .
Data were statistically analysed using the chi square test. Alpha-fetoprotein was tested for in 60 cirrhotics of whom 14 had dysplasia and all were negative. It was also tested for in 45 cirrhotics with liver cell carcinoma of whom 32 (71-1 %) were positive. There was no difference between those with and without dysplasia.
Results

PREVALENCE
Discussion
The results of this study suggest that liver cell dysplasia, as defined above, is a premalignant change. This rests on the following arguments.
Liver cell dysplasia is seen only occasionally in people suffering from a variety of diseases, including bile duct carcinoma and malignant tumours metastatic to the liver. It is present in a small proportion of normal livers bearing liver cell carcinoma. It is seen in approximately one-fifth of patients with cirrhosis and two-thirds of cirrhotics with liver cell carcinoma. This increase in prevalence from normal to cirrhosis and carcinoma is a statistically significant one.
Cirrhotic patients without dysplasia are, on average, 10 years younger than those with dysplasia and cirrhotics with dysplasia are, again on average, some six years younger than those with cirrhosis and carcinoma. This suggests that with time there is a progression of cirrhosis to dysplasia and, ultimately, to liver cell carcinoma. These age differences may be regarded as analogous to dysplasia, carcinoma insitu, and invasive carcinoma of the uterine cervix and other sites.
Dysplasia occurs significantly more frequently in males than in females, the differences being greatest amongst those with cirrhosis alone. In Uganda as elsewhere in Africa, there is a marked preponderance of males over females in liver cell carcinoma (Doll, Payne, and Waterhouse, 1966) and males with cirrhosis may have a higher chance of developing carcinoma than females (Shaper, 1970) . Both of these findings are further supported in this study.
Dysplasia is found almost exclusively in macronodular (posthepatitic and postnecrotic) types of cirrhosis and very rarely in the micronodular (nutritional, fatty) type. It is a well established fact that liver cell carcinoma arises most frequently in the grossly scarred, macronodular types of cirrhosis (Gall, 1960; Lee, 1966) . This was also found to be so in this study.
Available evidence suggests that there may be a geographical variability in the occurrence of liver cell dysplasia in that it appears to be less common in North America (Steiner and Davies, 1957) and in Europe (Scheuer, 1968) . This lower incidence would parallel the lower incidence of liver cell carcinoma in these areas (Doll et al, 1966) .
Liver cell dysplasia itself is not a malignant change, though its gross nuclear abnormalities, multifocal origin, and nodular pattern may cause difficulty in distinguishing it from nodules of liver cell carcinoma (Higginson and Steiner, 1961) . The main distinguishing features of dysplasia from carcinoma are the following:
Dysplastic liver cells show cytoplasmic as well as nuclear enlargement and, unlike liver cell carcinoma, the nuclear/cytoplasmic ratio remains within normal limits.
Cytoplasmic staining and granularity are usually normal in dysplasia whereas in liver cell carcinoma there is often some cytoplasmic basophilia.
In dysplastic nodules the reticulin pattern is usually normal or slightly increased whereas in carcinomatous nodules the reticulin is deficient or lost altogether.
Most importantly, this study has shown that the AFP test is negative in cirrhosis with dysplasia. If dysplasia itself was a malignant change a proportion of cases should be positive. Over 70% of liver cell carcinomas were AFP positive in this series.
The data presented in this study clarify the uncertainty expressed previously about the relationship between dysplasia and carcinoma. Steiner and Davies (1957) argued that as the morphological appearances of 'liver cell atypia' were different from liver cell carcinoma arising in the same liver, there was no relationship between them. There is, in fact, no reason why there should be a morphological similarity. Scheuer (1968) noted that atypical cellular changes could persist for years without carcinoma developing. This is compatible with the natural history of the lesion as described above and of dysplasia and carcinoma in situ at other sites. The precise nature of liver cell dysplasia remains uncertain. It is premalignant only in the sense that its presence is associated with an increased risk of liver cell carcinoma. It is of interest that it shows a strong association with the presence of HAA. We have shown previously that in Uganda there exists an approximately 10-fold increase in the prevalence of HAA in cirrhosis (Maynard, Sadikali, Anthony, and Barker, 1970) and liver cell carcinoma (Vogel, Anthony, Sadikali, and Barker, 1970) as compared with the general hospital population. We have also noted that liver cell dysplasia had a statistically significant association with the presence of HAA in both groups of patients . The data in this study are an extension of the earlier observations in a larger number of patients and are fully supportive. They suggest that dysplasia may indeed be causally related to HAA and chronic infection with the long-incubation (serum or B) hepatitis virus. The relative rarity of dysplastic changes in cirrhosis in the temperate zones (Steiner and Davies, 1957; Higginson and Steiner, 1961; Scheuer, 1968) would, on the other hand, parallel the low prevalence of HAA in these areas (Prince, 1971) .
Failure to find the typical virus-core-like particles in the nuclei of liver cells from 17 cases of liver cell carcinoma in this material (O'Conor, Tralka, Henson, and Vogel, 1972 ) is in contrast with the frequent finding of these particles in the hepatocytes of chronically infected, immunosuppressed patients (Huang, 1971) and asymptomatic HAA carriers (Caramia, De Bac, and Ricci, 1972) . This suggests a discordance between HAA production and virus synthesis in some patients with chronic virus B infection.
The work of Harris and his coworkers on cell fusion and malignancy may be relevant in this context (Harris, Miller, Klein, Worst, and Tachibana, 1969) . They showed that the malignant potential of cells from three types of tumours, one of which has been induced by polyomavirus,couldbe suppressed when fused with certain non-malignant cells. The hybrids resulting from such fusions produced segregants in which a loss of chromosomes was associated with reversion to malignant behaviour after a variable period of time. It may be speculated that HAA induces malignant change in liver cells which then fuse with normal liver cells in their vicinity to form large, abnormal, dysplastic cells. Malignancy is thereby suppressed. In some, this may be permanent; in others, the hybrid gradually escapes through loss of chromosomal material and malignant behaviour is then resumed. Much of the circumstantial evidence in this study supports this hypothesis. Ultimately, it is hoped that liver culture systems will be developed to test the effect of HAA-positive human material. Numerous examples of chromosomal abnormalities in cells infected with a wide variety of oncogenic and nononcogenic viruses have already been described (Aula, Nichols, and Levan, 1968) .
For practical purposes it may be suggested that the presence of liver cell dysplasia in a patient, particularly in the presence of cirrhosis, must be regarded as evidence of an increased risk of liver cell carcinoma. Such patients should be followed up by serial testing for alpha-fetoprotein. It is hoped that early detection of malignancy in this high risk group may lead to better results of surgical treatment for a tumour of which the prognosis is at present almost hopeless.
